Ziruvate may be available in the countries listed below.
Diltiazem hydrochloride (a derivative of Diltiazem) is reported as an ingredient of Ziruvate in the following countries:
International Drug Name Search
Cresadex may be available in the countries listed below.
Rosuvastatin is reported as an ingredient of Cresadex in the following countries:
Rosuvastatin calcium salt (a derivative of Rosuvastatin) is reported as an ingredient of Cresadex in the following countries:
International Drug Name Search
Clindamicina MK may be available in the countries listed below.
Clindamycin dihydrogen phosphate (a derivative of Clindamycin) is reported as an ingredient of Clindamicina MK in the following countries:
International Drug Name Search
Lerite may be available in the countries listed below.
Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Lerite in the following countries:
International Drug Name Search
Protoner may be available in the countries listed below.
Lansoprazole is reported as an ingredient of Protoner in the following countries:
International Drug Name Search
Lioplim may be available in the countries listed below.
Filgrastim is reported as an ingredient of Lioplim in the following countries:
International Drug Name Search
Chemmart Pravastatin may be available in the countries listed below.
Pravastatin is reported as an ingredient of Chemmart Pravastatin in the following countries:
International Drug Name Search
Desoxycortone Acetate may be available in the countries listed below.
Desoxycortone Acetate (BANM) is also known as Desoxycortone (Rec.INN)
International Drug Name Search
Glossary
| BANM | British Approved Name (Modified) |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Abodars may be available in the countries listed below.
Sodium Gualenate is reported as an ingredient of Abodars in the following countries:
International Drug Name Search
Inmunoartro may be available in the countries listed below.
Leflunomide is reported as an ingredient of Inmunoartro in the following countries:
International Drug Name Search
Hydroxocobalamine may be available in the countries listed below.
Hydroxocobalamine (DCF) is known as Hydroxocobalamin in the US.
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
Cinaflox may be available in the countries listed below.
Ciprofloxacin is reported as an ingredient of Cinaflox in the following countries:
International Drug Name Search
Gen-Divalproex may be available in the countries listed below.
Valproic Acid semisodium (a derivative of Valproic Acid) is reported as an ingredient of Gen-Divalproex in the following countries:
International Drug Name Search
Sequax may be available in the countries listed below.
Clozapine is reported as an ingredient of Sequax in the following countries:
International Drug Name Search
Ixia may be available in the countries listed below.
Olmesartan Medoxomil is reported as an ingredient of Ixia in the following countries:
International Drug Name Search
Ambroxolo Angenerico may be available in the countries listed below.
Ambroxol hydrochloride (a derivative of Ambroxol) is reported as an ingredient of Ambroxolo Angenerico in the following countries:
International Drug Name Search
Stavubergen may be available in the countries listed below.
Stavudine is reported as an ingredient of Stavubergen in the following countries:
International Drug Name Search
Fungicide may be available in the countries listed below.
Ketoconazole is reported as an ingredient of Fungicide in the following countries:
International Drug Name Search
Procaine Penicillin-G Meiji may be available in the countries listed below.
Benzylpenicillin procaine (a derivative of Benzylpenicillin) is reported as an ingredient of Procaine Penicillin-G Meiji in the following countries:
International Drug Name Search
Mevasterol may be available in the countries listed below.
Lovastatin is reported as an ingredient of Mevasterol in the following countries:
International Drug Name Search
Metronidazol Biocrom may be available in the countries listed below.
Metronidazole is reported as an ingredient of Metronidazol Biocrom in the following countries:
International Drug Name Search
Beclazone may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Beclometasone 17α,21-dipropionate (a derivative of Beclometasone) is reported as an ingredient of Beclazone in the following countries:
International Drug Name Search
Rec.INN
C01BD02
0000061-75-6
C18-H24-Br-N-O3-S
414
Antihypertensive agent
Benzenemethanaminium, 2-bromo-N-ethyl-N,N-dimethyl-, salt with 4-methylbenzenesulfonic acid (1:1)
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
Rilatine may be available in the countries listed below.
Methylphenidate hydrochloride (a derivative of Methylphenidate) is reported as an ingredient of Rilatine in the following countries:
International Drug Name Search
Pharothrocin may be available in the countries listed below.
Erythromycin ethylsuccinate (a derivative of Erythromycin) is reported as an ingredient of Pharothrocin in the following countries:
Erythromycin stearate (a derivative of Erythromycin) is reported as an ingredient of Pharothrocin in the following countries:
International Drug Name Search
The following drugs and medications are in some way related to, or used in the treatment of Perimenopausal Symptoms. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Hexoestrol may be available in the countries listed below.
Hexestrol is reported as an ingredient of Hexoestrol in the following countries:
International Drug Name Search
Domidine may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Detomidine hydrochloride (a derivative of Detomidine) is reported as an ingredient of Domidine in the following countries:
International Drug Name Search
Minims Fluorescein Sodium may be available in the countries listed below.
Fluorescein sodium (a derivative of Fluorescein) is reported as an ingredient of Minims Fluorescein Sodium in the following countries:
International Drug Name Search
Yodoclin may be available in the countries listed below.
Povidone-Iodine is reported as an ingredient of Yodoclin in the following countries:
International Drug Name Search
Citrovit-L.S. may be available in the countries listed below.
Ascorbic Acid is reported as an ingredient of Citrovit-L.S. in the following countries:
International Drug Name Search
Sedamed may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Medetomidine hydrochloride (a derivative of Medetomidine) is reported as an ingredient of Sedamed in the following countries:
International Drug Name Search
Cecrisina may be available in the countries listed below.
Ascorbic Acid is reported as an ingredient of Cecrisina in the following countries:
International Drug Name Search
Vulketan may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Ketanserin is reported as an ingredient of Vulketan in the following countries:
Ketanserin tartrate (a derivative of Ketanserin) is reported as an ingredient of Vulketan in the following countries:
International Drug Name Search
Ketron may be available in the countries listed below.
Ketoprofen is reported as an ingredient of Ketron in the following countries:
Ketorolac tromethamine (a derivative of Ketorolac) is reported as an ingredient of Ketron in the following countries:
International Drug Name Search
Konakin may be available in the countries listed below.
Phytomenadione is reported as an ingredient of Konakin in the following countries:
International Drug Name Search
Colpogyn may be available in the countries listed below.
Estriol is reported as an ingredient of Colpogyn in the following countries:
International Drug Name Search
Haloperidol Gemepe may be available in the countries listed below.
Haloperidol is reported as an ingredient of Haloperidol Gemepe in the following countries:
International Drug Name Search
Logroton may be available in the countries listed below.
Chlortalidone is reported as an ingredient of Logroton in the following countries:
Metoprolol tartrate (a derivative of Metoprolol) is reported as an ingredient of Logroton in the following countries:
International Drug Name Search
Charbon de belloc may be available in the countries listed below.
Charcoal, Activated is reported as an ingredient of Charbon de belloc in the following countries:
International Drug Name Search
Generic Name: BCG (bee cee jee)
Brand names: TheraCys, Tice BCG Vaccine, Theracys 3, Tice BCG Live (for intravesical use), BCG Vaccine
BCG (Bacillus Calmette and Guérin) is made using the organisms of a bacteria.
This medication is injected directly into the bladder, where it causes inflammation and increases certain white blood cells known as natural killer cells. These killer cells act to destroy invading cells such as tumor cells in the bladder.
BCG is used to treat bladder cancer that is localized (has not spread to other parts of the body).
BCG may also be used for other purposes not listed in this medication guide.
You should also not receive BCG if you have had a bladder biopsy, surgery, or catheter within the past 14 days.
Before you receive BCG, tell your doctor if you are allergic to latex rubber, or if you have myasthenia gravis, a pacemaker or other artificial heart device, an artificial joint or other prosthetic, or any type of infection (including HIV).
Also tell your doctor if you have ever had tuberculosis, bypass surgery, or an aneurysm (dilated blood vessel), or if you currently need to have an organ transplant (kidney, liver, heart, etc).
Your doctor may ask you to drink extra fluids for several hours after your BCG treatment to help flush out your bladder. Follow your doctor's instructions about the type and amount of liquids you should drink.
tuberculosis;
a weak immune system from diseases such as AIDS, leukemia, or lymphoma;
fever, a bladder infection, or blood in your urine;
if you are using steroids or receiving chemotherapy or radiation treatments; or
if you have had a bladder biopsy, surgery, or catheter within the past 14 days.
Before you receive BCG, tell your doctor if you are allergic to latex rubber, or if you have:
any type of bacterial, fungal, or viral infection (including HIV);
myasthenia gravis;
a pacemaker or other artificial heart device;
an artificial joint or other prosthetic;
a history of aneurysm (dilated blood vessel);
if you have ever had bypass surgery;
if you have ever had tuberculosis; or
if you need to have an organ transplant (kidney, liver, heart, etc).
If you have any of these conditions, you may need a dose adjustment or special tests to safely receive BCG.
BCG is a freeze-dried product that is mixed with saline and other diluents (liquids) in an amount equal to approximately 8 ounces. This liquid mixture is injected directly into the bladder using a catheter inserted into the urethra (the tube for passing urine out of your bladder). You will receive this medication in a clinic or hospital setting.
This medication is usually given once every week for 6 weeks, and then given every 3 to 6 months for up to 2 years. Follow your doctor's instructions about your specific dosing schedule.
After BCG is placed into the bladder, you will need hold the medication in your bladder as long as possible up to 2 hours. During that time you may be encouraged to lie down or stay relaxed.
Before you flush the toilet, disinfect the urine with household bleach in an amount that is approximately equal to how much you have urinated. Pour the bleach into the toilet in which you urinated, let it stand for 15 minutes and then flush.
Your doctor may ask you to drink extra fluids for several hours after your BCG treatment to help flush out your bladder. Follow your doctor's instructions about the type and amount of liquids you should drink.
Being treated with BCG can cause you to have unusual results with certain medical tests. Tell any doctor who treats you that you are using BCG.
Call your doctor for instructions if you miss an appointment for your BCG treatment.
Overdose symptoms may include signs of an infection, such as fever, chills, body aches, weakness, or other flu symptoms.
fever, chills, cough, body aches, joint pain, weakness, vomiting, or other flu symptoms;
nausea, vomiting, stomach pain, jaundice (yellowing of your skin or eyes);
pain or burning when you urinate;
difficult urination;
more frequent or urgent urinating;
blood in your urine, lower back pain;
pain or swelling in your testicles;
easy bruising or bleeding;
eye pain, redness, watering, severe burning or itching; or
vision changes, increased sensitivity to light.
Less serious side effects may include:
mild nausea, stomach pain, or loss of appetite;
mild bladder or groin pain;
urine leakage or incontinence;
diarrhea, constipation;
headache;
mild skin rash;
dizziness, tired feeling; or
tissue particles in your urine (not blood).
This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.
Usual Adult Dose for Tuberculosis -- Prophylaxis:
BCG vaccine for use in tuberculosis prophylaxis:
BCG vaccine is reserved for persons who have a reaction of
The immunizing dose of 0.2 to 0.3 mL of BCG vaccine is dropped from the syringe and needle onto the cleansed surface of the skin and spread over a 1" by 2" area using the edge of the multiple puncture device. The vaccine is administered percutaneously using a sterile multiple puncture device. The preferred site is the deltoid region. The multiple puncture device is centered over the vaccine and firm downward pressure is applied such that the device points are buried into the skin. Pressure should be maintained for five seconds. (The device should not be rocked.) Pressure underneath the arm is then released and the device is removed.
If the procedure is successful, the points will have punctured the skin. If the points only indent the skin, then the procedure must be repeated.
After a successful procedure, the vaccine should be spread as evenly as possible over the puncture area with the edge of the device. An additional 1 to 2 drops of BCG vaccine may be added to ensure a very wet vaccination site.
The patient should be tuberculin skin tested two to three months after BCG administration. BCG vaccination should be repeated for those who remain tuberculin negative to 5 TU of tuberculin after two to three months.
Usual Adult Dose for Urinary Tumor:
Intravesical BCG for use in the treatment of urinary tumors:
Do not inject subcutaneously or intravenously.
The initial dosage of BCG for intravesical use recommended for this patient is one vial administered by intravesical installation into the urinary bladder.
TICE BCG (for intravesical use): The dose for the intravesical treatment of carcinoma in situ and for the prophylaxis of recurrent papillary tumors consists of one vial of BCG suspended in 50 mL preservative-free saline.
A standard TICE BCG treatment schedule consists of one intravesical instillation per week for six weeks. This schedule may be repeated once if tumor remission has not been achieved and if the clinical circumstances warrant. Intravesical TICE BCG administration should then continue at approximately monthly intervals for at least six to twelve months.
TheraCys (for intravesical use): One dose of TheraCys BCG Live consists of the intravesical instillation of 81 mg (dry weight) BCG. This dose is prepared by reconstituting the vial containing freeze-dried BCG with the contents of the vial containing diluent. The vial of reconstituted BCG is further diluted in 50 mL of sterile, preservative-free saline, for a total of 53 mL instillation volume.
A standard TheraCys BCG treatment schedule also consists of one intravesical instillation per week for six weeks. However, the TheraCys therapy then continues on to one dose administered at 3, 6, 12, 18, and 24 months following the initial dose.
Usual Pediatric Dose for Tuberculosis -- Prophylaxis:
Safety and effectiveness of intravesical BCG for the treatment of superficial bladder cancer in pediatric patients have not been established.
BCG vaccine for use in tuberculosis prophylaxis:
BCG vaccine is reserved for persons who have a reaction of
The vaccine is administered percutaneously using a sterile multiple puncture device. The preferred site is the deltoid region.
Generally, 1 mL of sterile water for injection is added to one vial of vaccine. However, in infants less than one month old, the dosage of BCG vaccine should be reduced by one half by using 2 mL of sterile water for injection when reconstituting the vial.
The immunizing dose of 0.2 to 0.3 mL of BCG vaccine is dropped from the syringe and needle onto the cleansed surface of the skin and spread over a 1" by 2" area using the edge of the multiple puncture device. The multiple puncture device is centered over the vaccine and firm downward pressure is applied such that the device points are buried into the skin. Pressure should be maintained for five seconds. (The device should not be rocked.) Pressure underneath the arm is then released and the device is removed.
If the procedure is successful, the points will have punctured the skin. If the points only indent the skin, then the procedure must be repeated.
After a successful procedure, the vaccine should be spread as evenly as possible over the puncture area with the edge of the device. An additional 1 to 2 drops of BCG vaccine may be added to ensure a very wet vaccination site.
The patient should be tuberculin skin tested two to three months after BCG administration. BCG vaccination should be repeated for those who remain tuberculin negative to 5 TU of tuberculin after two to three months. For infants vaccinated at less than one month of age, if the vaccinated infant remains tuberculin negative for 5 TU on skin testing, and if indications for vaccination persist, the infant should receive a full dose after one year of age..
Before you receive BCG, tell your doctor if you are taking an antibiotic, or if you are using any drugs that weaken your immune system, such as:
cancer medicine or radiation;
cyclosporine (Neoral, Sandimmune, Gengraf);
sirolimus (Rapamune), tacrolimus (Prograf);
basiliximab (Simulect), efalizumab (Raptiva), muromonab-CD3 (Orthoclone);
mycophenolate mofetil (CellCept);
azathioprine (Imuran), leflunomide (Arava), etanercept (Enbrel); or
steroids such as prednisone, fluticasone (Advair), mometasone (Asmanex, Nasonex), dexamethasone (Decadron, Hexadrol) and others.
This list is not complete and there may be other drugs that can interact with BCG. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.
See also: BCG side effects (in more detail)
Cemin may be available in the countries listed below.
Ascorbic Acid is reported as an ingredient of Cemin in the following countries:
International Drug Name Search
Paxidorm may be available in the countries listed below.
Diphenhydramine hydrochloride (a derivative of Diphenhydramine) is reported as an ingredient of Paxidorm in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
Tricaine mesilate (a derivative of Tricaine) is reported as an ingredient of Tricaine S in the following countries:
International Drug Name Search
Alergitrat may be available in the countries listed below.
Chlorphenamine maleate (a derivative of Chlorphenamine) is reported as an ingredient of Alergitrat in the following countries:
International Drug Name Search
Daktarin Topico may be available in the countries listed below.
Miconazole nitrate (a derivative of Miconazole) is reported as an ingredient of Daktarin Topico in the following countries:
International Drug Name Search
Biodol may be available in the countries listed below.
Tramadol hydrochloride (a derivative of Tramadol) is reported as an ingredient of Biodol in the following countries:
International Drug Name Search
Alantan-Plus may be available in the countries listed below.
Allantoin is reported as an ingredient of Alantan-Plus in the following countries:
Dexpanthenol is reported as an ingredient of Alantan-Plus in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
In the US, Cosmegen (dactinomycin systemic) is a member of the drug class antibiotics/antineoplastics and is used to treat Cancer, Ewing's Sarcoma, Osteoarthritis, Osteosarcoma, Ovarian Cancer, Rhabdomyosarcoma, Testicular Cancer, Trophoblastic Disease and Wilms' Tumor.
US matches:
Dactinomycin is reported as an ingredient of Cosmegen in the following countries:
International Drug Name Search
Adine may be available in the countries listed below.
Norepinephrine tartrate (a derivative of Norepinephrine) is reported as an ingredient of Adine in the following countries:
International Drug Name Search
Glimepirida Cinfa may be available in the countries listed below.
Glimepiride is reported as an ingredient of Glimepirida Cinfa in the following countries:
International Drug Name Search
Penicillin V dura may be available in the countries listed below.
Phenoxymethylpenicillin potassium (a derivative of Phenoxymethylpenicillin) is reported as an ingredient of Penicillin V dura in the following countries:
International Drug Name Search
Calci may be available in the countries listed below.
Calcium Pantothenate is reported as an ingredient of Calci in the following countries:
International Drug Name Search
BAN
B06AA07,D03BA01
0009002-07-7
Wound healing agent
Proteolytic enzyme
Proteolytic enzyme crystallized from an extract of the pancreas gland of the ox, Bos taurus
International Drug Name Search
Glossary
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
Oxybutynine Mylan may be available in the countries listed below.
Oxybutynin hydrochloride (a derivative of Oxybutynin) is reported as an ingredient of Oxybutynine Mylan in the following countries:
International Drug Name Search
Alivian may be available in the countries listed below.
Ranitidine hydrochloride (a derivative of Ranitidine) is reported as an ingredient of Alivian in the following countries:
International Drug Name Search
Antiparkin may be available in the countries listed below.
Carbidopa is reported as an ingredient of Antiparkin in the following countries:
Levodopa is reported as an ingredient of Antiparkin in the following countries:
Selegiline hydrochloride (a derivative of Selegiline) is reported as an ingredient of Antiparkin in the following countries:
International Drug Name Search
Ciprofloxacin Axapharm may be available in the countries listed below.
Ciprofloxacin hydrochloride (a derivative of Ciprofloxacin) is reported as an ingredient of Ciprofloxacin Axapharm in the following countries:
International Drug Name Search
Scopamin Plus may be available in the countries listed below.
Paracetamol is reported as an ingredient of Scopamin Plus in the following countries:
Scopolamine butylbromide (a derivative of Scopolamine) is reported as an ingredient of Scopamin Plus in the following countries:
International Drug Name Search
Rimsalin may be available in the countries listed below.
Lincomycin hydrochloride monohydrate (a derivative of Lincomycin) is reported as an ingredient of Rimsalin in the following countries:
International Drug Name Search
Optamax may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Albendazole is reported as an ingredient of Optamax in the following countries:
Ivermectin is reported as an ingredient of Optamax in the following countries:
International Drug Name Search
Definition of Corneal Ulcer:
An infectious process of the cornea, resulting in clouding of the cornea, marked eye pain and decreased vision.
See: Herpes simplex keratitis.
More...
The following drugs and medications are in some way related to, or used in the treatment of Corneal Ulcer. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
Medical Encyclopedia:
Percutaféine may be available in the countries listed below.
Caffeine is reported as an ingredient of Percutaféine in the following countries:
International Drug Name Search
Prevalin may be available in the countries listed below.
Cromoglicic Acid disodium salt (a derivative of Cromoglicic Acid) is reported as an ingredient of Prevalin in the following countries:
International Drug Name Search
Odan K-20 may be available in the countries listed below.
Potassium Chloride is reported as an ingredient of Odan K-20 in the following countries:
International Drug Name Search
Méthoxamine may be available in the countries listed below.
Méthoxamine (DCF) is known as Methoxamine in the US.
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
Treating neovascular (wet) age-related macular degeneration (AMD). It is also used for treating another certain eye problem known as macular edema following retinal vein occlusion (RVO).
Ranibizumab is a selective vascular endothelial growth factor (VEGF) antagonist. It works by decreasing the growth of certain cells in the eye. It also helps to keep blood vessels in the eye from leaking and decreases the formation of new blood vessels in the eye. This slows or stops wet AMD and macular edema following RVO.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Ranibizumab. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Ranibizumab. However, no specific interactions with Ranibizumab are known at this time.
Ask your health care provider if Ranibizumab may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Ranibizumab as directed by your doctor. Check the label on the medicine for exact dosing instructions.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Dry eye; eye discomfort; feeling of something in the eye; headache; increased tears; nausea; nose or throat irritation; seeing floaters or spots.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); chest, jaw, or left arm pain; decreased vision or other vision changes; eye or eyelid swelling; eye pain, pressure, redness, bleeding, or discharge; sensitivity to light; symptoms of infection (eg, fever, chills, persistent sore throat); symptoms of a stroke (eg, one-sided weakness, slurred speech, confusion).
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Ranibizumab side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include eye swelling. Ranibizumab may be harmful if swallowed.
Ranibizumab is usually handled and stored by a health care provider. If you are using Ranibizumab at home, store Ranibizumab as directed by your pharmacist or health care provider. Keep Ranibizumab out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Ranibizumab. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Rec.INN
0150915-41-6
C23-H30-N4-O2-S
426
Neuroleptic
cis-N-[4-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]butyl]-1,2-cyclohexanedicarboximide (WHO)
(3aR,7aS)-rel-2-[4-[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]butyl]hexahydro-1H-isoindole-1,3(2H)-dione
International Drug Name Search
Glossary
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| WHO | World Health Organization |
APC Marel may be available in the countries listed below.
Acetylsalicylic Acid is reported as an ingredient of APC Marel in the following countries:
Paracetamol is reported as an ingredient of APC Marel in the following countries:
International Drug Name Search
Valdex may be available in the countries listed below.
Valdecoxib is reported as an ingredient of Valdex in the following countries:
International Drug Name Search
Pravalon may be available in the countries listed below.
Pravastatin sodium salt (a derivative of Pravastatin) is reported as an ingredient of Pravalon in the following countries:
International Drug Name Search
In the US, Paracetamol Sandoz is a member of the drug class miscellaneous analgesics and is used to treat Fever, Muscle Pain, Pain and Sciatica.
Paracetamol is reported as an ingredient of Paracetamol Sandoz in the following countries:
International Drug Name Search
Adreject may be available in the countries listed below.
Epinephrine is reported as an ingredient of Adreject in the following countries:
International Drug Name Search
Prometazina Vannier may be available in the countries listed below.
Promethazine hydrochloride (a derivative of Promethazine) is reported as an ingredient of Prometazina Vannier in the following countries:
International Drug Name Search
Asigen may be available in the countries listed below.
Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Asigen in the following countries:
International Drug Name Search
Esmolol Orpha may be available in the countries listed below.
Esmolol hydrochloride (a derivative of Esmolol) is reported as an ingredient of Esmolol Orpha in the following countries:
International Drug Name Search
See also: Generic Lidex
Lidex-E is a brand name of fluocinonide topical, approved by the FDA in the following formulation(s):
Yes. The following products are equivalent to Lidex-E:
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Lidex-E. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
There are no current U.S. patents associated with Lidex-E.
Atusil may be available in the countries listed below.
Promolate is reported as an ingredient of Atusil in the following countries:
International Drug Name Search
Ark Klens may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Benzalkonium chloride (a derivative of Benzalkonium) is reported as an ingredient of Ark Klens in the following countries:
International Drug Name Search
Estramustina may be available in the countries listed below.
Estramustina (DCIT) is known as Estramustine in the US.
International Drug Name Search
Glossary
| DCIT | Denominazione Comune Italiana |
Flucostan may be available in the countries listed below.
Fluconazole is reported as an ingredient of Flucostan in the following countries:
International Drug Name Search
